Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRC 018: HIV-1 Vaccine Trimer 4571 with Alum in Healthy Adults
NCT03783130Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2019
- Primary completion
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of trimer 4571 in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2019; status: completed.
02
Drugs
trimer 4571
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03783130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783130.